Skip to content

Clinical trials

Phase 1 Multiple Myeloma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 1 Country / region: Japan Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20114
20122
20131
20143
20151
20162
20173
20182
20193
20202
20214
20225
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated12
Active, not recruiting4
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
Janssen Pharmaceutical K.K.8
Novartis Pharmaceuticals5
Amgen3
Celgene3
Bristol-Myers Squibb2
Pfizer2
Celgene Corporation1
Eli Lilly and Company1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma38
Recurrence9
Neoplasms7
Leukemia, Myeloid, Acute5
Lymphoma, Non-Hodgkin5
Lymphoma2
Myelodysplastic Syndromes2
Amyloidosis1
Hematologic Neoplasms1
Hodgkin Disease1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.